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Abstract
Sleep disruption, which includes a loss of sleep as well as poor quality fragmented sleep, 
frequently follows traumatic brain injury (TBI) impacting a large number of patients each year in 
the United States. Fragmented and/or disrupted sleep can worsen neuropsychiatric, behavioral, and 
physical symptoms of TBI. Additionally, sleep disruption impairs recovery and can lead to 
cognitive decline. The most common sleep disruption following TBI is insomnia, which is 
difficulty staying asleep. The consequences of disrupted sleep following injury range from 
deranged metabolomics and blood brain barrier compromise to altered neuroplasticity and 
degeneration. There are several theories for why sleep is necessary (e.g., glymphatic clearance and 
metabolic regulation) and these may help explain how sleep disruption contributes to degeneration 
within the brain. Experimental data indicate disrupted sleep allows hyperphosphorylated tau and 
amyloid β plaques to accumulate. As sleep disruption may act as a cellular stressor, target areas 
warranting further scientific investigation include the increase in endoplasmic reticulum and 
oxidative stress following acute periods of sleep deprivation. Potential treatment options for 
restoring the normal sleep cycle include melatonin derivatives and cognitive behavioral therapy.
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Seven million traumatic brain injuries (TBIs) occur each year in the United States. Motor 
vehicle collisions, which can cause concussions, account for ~45% of exposure (Scholten et 
al., 2014). Additionally, blast TBI has been classified as the ‘signature injury’ of modern 
warfare (Goldstein et al., 2012). The upsurge in TBI has prompted a renewed interest by the 
lay and scientific communities in the chronic sequelae that follows these injuries. One of the 
most common sequelae in patients exposed to TBI is disrupted sleep, which is especially 
common following mild TBI (Stocker et al., 2014). By definition, mild TBI involves a loss 
of consciousness less than 30 min and no skull fracture; moderate TBI a loss of 
consciousness between 30 min and 24 h, with or without skull fracture; and severe TBI a 
loss of consciousness greater than 24 h, with contusion, hematoma, or skull fracture. A 
concussion may occur with or without a loss of consciousness and falls under the category 
of a mild TBI. Exposure to blast, on the other hand, can also produce moderate and severe 
TBI.
The factors contributing to sleep disruption in TBI include damage to brain areas controlling 
the circadian rhythm, an increase in intracranial pressure that causes changes to the 
parasympathetic nervous system, and alterations in vascular tone. In addition, disrupted 
sleep often manifests with neuropsychiatric symptoms such as cognitive deficits, depression, 
disorientation, and anxiety (Farinde, 2014). These sleep and neuropsychiatric changes can 
develop independently or as part of several chronic neurodegenerative diseases such as 
Alzheimer’s disease (AD), chronic traumatic encephalopathy (CTE), and Parkinson’s 
disease instigated by TBI (Cipriani et al., 2014; Goetz and Pal, 2014). Little is known about 
the etiology of TBI-induced sleep disturbance and emotional labiality, but the growing 
awareness of sleep disorders in TBI patients warrants further investigation. Moreover, the 
change in sleep patterns and other symptoms following the different mechanisms of brain 
injury may be distinct. In this review, we focus on mild TBI, as the literature suggests sleep 
disruption is most often associated with this form of TBI. We discuss in particular sleep 
disruption from maintenance insomnia as a result of mild TBI, neuropsychiatric (including 
cognitive, emotional, and behavioral dysfunctions) and physical symptoms of TBI, and how 
sleep disturbances may affect the other post-TBI symptoms. Finally, we propose potential 
mechanisms of brain damage following TBI that may lead to sleep dysfunction. Areas of 
particular interest include changes in brain metabolomics, changes in vascular flow, 
alterations in neurogenesis, and progression to neurodegeneration.
2. Sleep and TBI
Sleep is believed to be necessary for recovery following TBI. Sleep disturbance can lead to 
cognitive deficits and poor overall functioning (Duclos et al., 2014). In the following 
section, we discuss types of sleep disturbance and what is known from clinical studies.
2.1. Types of sleep disturbances
Sleep fragmentation, defined as a slightly reduced amount of sleep with not much slow wave 
activity, is the most common sleep disorder immediately following injury with increased 
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night terrors at later time points (Macera et al., 2013). Moreover, mild TBI has long been 
recognized to cause sleep-wake disturbances and excessive daytime sleepiness, but the 
precise mechanisms behind these changes remain unclear (Verma et al., 2007). Numerous 
clinical studies have identified increases in excessive daytime sleepiness in 25–50% of 
patients, with up to half of those patients experiencing severe hypersomnia (Baumann et al., 
2007; Masel et al., 2001). The increase in daytime somnolence may be associated with 
impaired daily function, mood changes, and alterations in circadian rhythms (Verma et al., 
2007), and explained by decreased sleep efficiency and increased waking after sleep onset, 
maintenance insomnia, in those experiencing TBI (Shekleton et al., 2010). Sleep efficiency 
is the percentage of time spent sleeping during the scheduled sleep period.
In an attempt to more thoroughly explore the relationship of sleep disturbances to TBI in a 
controlled environment, numerous investigators have employed preclinical rodent models. 
In one study, injured rodents had shortened wake bouts during the normal period of activity 
(dark phase), indicating that injury produced wake fragmentation (Skopin et al., 2014). 
These changes were accompanied by a decrease in orexin-A-positive neurons–neurons 
important for arousal. The decrease may represent a down-regulation of orexin-A or an 
actual loss of the neurons. Another study by Petraglia and colleagues found that both single 
and repeat injury were associated with an increase in wake time and a concomitant reduction 
in non-rapid eye movement (NREM) sleep (Petraglia et al., 2014). Similarly, repetitive TBI 
was also associated with NREM sleep fragmentation, affecting both the number and length 
of fragmentation episodes (Petraglia et al., 2014).
Mild TBI rather than severe TBI is most commonly associated with sleep disturbances 
(Mahmood et al., 2004; Pillar et al., 2003). Maintenance insomnia is the most commonly 
reported sleep disturbance and is associated with milder TBI, higher levels of fatigue, 
depression, and pain (Ouellet et al., 2004). Insufficient pain management is a primary 
contributor to increased insomnia in patients with mild TBI (Lavigne et al., 2015). Mild TBI 
is also often repetitive, which increases the likelihood for insomnia (Jain et al., 2014). In a 
survey of 452 individuals with TBI, 50.2% reported insomnia symptoms and 29.4% fulfilled 
the DSM-IV diagnostic criteria for an insomnia syndrome (Ouellet et al., 2006). Of those 
who fulfilled the criteria, their insomnia was reported as severe and was left untreated in 
nearly 60% of the cases. In other studies sleep deprivation, defined as loss of hours of sleep, 
is reported 30–80% of the time after mild TBI (Clinchot et al., 1998; Fichtenberg et al., 
2002; Ouellet et al., 2006; Parcell et al., 2006). These symptoms may persist for months to 
years and have been demonstrated by self-report (Cohen et al., 1992) as well as by 
polysomnography and actigraphy monitoring 3 years after injury (Kaufman et al., 2001). 
Other sleep disturbances such as sleep apnea, narcolepsy, and periodic limb movements are 
associated with TBI but are not the focus of this review (Castriotta et al., 2007; Verma et al., 
2007).
Objective findings of sleep disturbance following TBI include frequent nighttime 
awakenings (Kaufman et al., 2001), higher proportions of stage 1 sleep (Ouellet and Morin, 
2006) and stage 2 sleep (Schreiber et al., 2008), decreased percentage of rapid eye 
movement (REM) sleep (Parcell et al., 2008), and shorter REM sleep latencies (Ouellet and 
Morin, 2006). Overall individuals with sleep disturbance after TBI have been found to have 
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lower efficiency of sleep than matched controls (Kaufman et al., 2001). Disruption in 
circadian rhythm is found in 7–10% of individuals who initially report insomnia although 
this disruption may go unrecognized by patients and clinicians alike (Weitzman et al., 1981). 
Circadian rhythm sleep disorders, defined as a disruption in the normal 24-hour cycle of 
physiological processes, are associated with alterations in body temperature and melatonin 
secretion rhythms (Shibui et al., 1999; Uchiyama et al., 2000). In a recent case report, TBI 
has been shown to have an association with circadian rhythm sleep disorders (Quinto et al., 
2000) and there is emerging evidence that it may contribute to their onset (Ayalon et al., 
2007).
3. Neuropsychiatric and physical symptoms of TBI
TBI can result in substantive cognitive, emotional and behavioral disorders (Arciniegas et 
al., 2000; Rao and Lyketsos, 2000), all of which are associated with increased morbidity 
(Arciniegas et al., 2000). Along with the cognitive or behavioral symptoms, some physical 
symptoms that may arise following TBI include headache, lightheadedness, tinnitus, 
dizziness, blurred vision, fatigue, and muscle or joint pain (MacGregor et al., 2013). We 
highlight some of these changes associated with mild TBI below.
3.1. Effect of TBI on cognition
Cognitive impairment represents one of the primary deficits associated not only with acute 
TBI but also chronic disease following TBI, including AD and CTE (Tateno et al., 2014). In 
fact, cognitive abilities are impaired in nearly all individuals with a history of TBI (Rao and 
Lyketsos, 2000). Evidence indicates that cognitive deficits following TBI may be influenced 
by the severity of TBI, as they have been related to the degree of axonal injury, the presence 
and duration of loss of consciousness, post-traumatic amnesia, and the degree of brainstem 
injury (Rao and Lyketsos, 2000). In cases of mild TBI, the cognitive deficits may include 
but are not limited to disruptions in attention, concentration, memory, language, and even 
arousal/alertness (Lux, 2007; Rao and Lyketsos, 2000). The emergence of cognitive deficits 
is also largely brain area dependent, with frontal injury being associated with impairments of 
executive functioning (Lux, 2007), which affects a number of functions required for 
everyday survival including goal selection, anticipation, initiation, planning, sequencing, 
self-correction, and error-detection. Additionally, a lack of awareness and subsequent 
diminished insight is typically seen in those with moderate injuries affecting the frontal lobe 
(Lux, 2007).
3.2. Effect of TBI on behavior and mood
Behavioral and mood disturbances are also commonplace after TBI, and are likely related to 
disruption or damage to monoaminergic pathways important for regulating emotion and 
behavior (Jorge and Robinson, 2003; Lux, 2007). These disturbances range from depression 
to affective lability, irritability, anxiety, and psychosis, with depression occurring the most 
often post-TBI (Bailey et al., 2014). The incidence of reported cases of depression in this 
population ranges between 10 and 77% (Alderfer et al., 2005; Malkesman et al., 2013; 
Rogers and Read, 2007; van Reekum et al., 2000). This varied incidence range may be due 
to differences in diagnostic criteria, time post-injury when the diagnosis of depression is 
Lucke-Wold et al. Page 4













made, and differences in the mechanism of injury (Alderfer et al., 2005; Malkesman et al., 
2013). Depression post-injury is especially prominent in female patients as well as those 
who are younger and who have a history of prior mental health treatment, substance abuse, 
or a self-inflicted injury (Hart et al., 2011; Valk-Kleibeuker et al., 2014). While the rate and 
risk of developing depression is highest in the year immediately following injury, the risk 
continues to remain elevated above baseline for many years (Holsinger et al., 2002; Jorge et 
al., 1993; Malkesman et al., 2013). Symptoms associated with depression include feelings of 
loss, demoralization, discouragement, dysphoria, fatigue, irritability, anhedonia, disinterest, 
insomnia, general apathy, and suicidal ideation (Hinkeldey and Corrigan, 1990; Malkesman 
et al., 2013; Rao and Lyketsos, 2000; van Zomeren and van den Burg, 1985). Suicidal 
ideation and suicidal attempts clearly represent the most severe form of depression. The 
number of suicidal attempts is elevated post-TBI with rates 2.7–4 times higher than that of 
the general population. This is particularly true amongst veterans; especially those who 
underwent repeated deployment (Burns et al., 1994; Malkesman et al., 2013; Mann et al., 
1999; Persinger, 1994; Simpson and Tate, 2002; Teasdale and Engberg, 2001).
Along with depression, TBI is also associated with the development of an array of anxiety-
related disorders, including generalized anxiety disorder, post-traumatic stress disorder 
(PTSD) and obsessive–compulsive disorder. Much like depression, the true incidence of 
anxiety post-TBI is unclear with reports ranging from 11 to 70% (Klonoff, 1971; Rao and 
Lyketsos, 2000). The most common anxiety phenotype exhibited, termed generalized ‘free-
floating’ anxiety, consists of persistent worry accompanied by stress and fearfulness (Lewis 
and Rosenberg, 1990; Rao and Lyketsos, 2000). In addition, patients sustaining mild TBI are 
more likely to develop anxiety-based disorders than those with moderate or severe injury 
(Mallya et al., 2014).
Least well studied of the disorders associated with TBI are the psychotic disorders. 0.7–
9.8% of TBI patients develop schizophrenic-like psychosis, despite little or no family 
history (Abdel Malik et al., 2003). Additionally, prior head injury has been identified in 
nearly 15% of patients diagnosed with schizophrenia, providing further evidence of a 
potential relationship or correlation (Nasrallah et al., 1981). Psychotic symptoms associated 
with TBI are wide ranging and all encompassing with reports of delusions, hallucinations, 
illogical thinking, agitation, ideas of reference, grimacing, regression, and impulsive 
aggressiveness (Brown et al., 1981; Thomsen, 1984). Unipolar mania and classical bipolar 
disorder have also been observed post-injury but these reports were in the form of case 
series or reports without large studies being conducted (Bakchine et al., 1989; Lux, 2007; 
Pope et al., 1988).
3.3. Anatomic site of TBI-induced damage influences deficits
The location of TBI damage is generally believed to be of critical importance to the genesis 
of neuropsychiatric symptoms mentioned above. For example, damage to the dorsolateral 
prefrontal convexity has been associated with cognitive executive disorders whereas 
behavioral disorders are generally associated with orbital frontal and ventromedial damage 
(Grafman et al., 1996; Lux, 2007). In patients with reported episodic dyscontrol syndromes 
or intermittent explosive disorder, damage is frequently observed within the temporal lobes 
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(Grafman et al., 1996; Lux, 2007). Mood-related symptoms, such as depression, may be 
related to disruption of monoaminergic pathways passing through the basal ganglia and/or 
frontal-subcortical white matter (Rao and Lyketsos, 2000; Starkstein et al., 1987). The 
probability of developing major depressive disorder is highest in those with left dorsolateral 
frontal and left basal ganglia lesions (Fedoroff et al., 1992; Rao and Lyketsos, 2000). 
Apathy, often associated with depression, may be due to mesial frontal lobe damage (Duffy 
and Campbell, 1994; Rao and Lyketsos, 2000). Post-TBI anxiety on the other hand is the 
result of disruption of similar monoaminergic pathways but is confounded by inhibition of 
GABA networks (Paul, 1988). Notably, right-sided lesions tend to be associated with 
anxiety more so than left-sided lesions (Jorge et al., 1993; Rao and Lyketsos, 2000).
3.4. Physical manifestations of TBI
Headache appears to be the most common symptom reported following mild TBI, though 
the prevalence has ranged from 30 to 90% in retrospective studies with around 20% lasting 
more than a year (Theeler et al., 2013). Moreover, Hoge and colleagues reported that after 
adjustment for PTSD and depression, headache was the only post-injury symptom 
significantly associated with mild TBI among 2525 US infantry soldiers (Hoge et al., 2008). 
Though the data are limited, a few human studies have assessed changes in vagal activity 
after TBI in the acute phase. The increase in parasympathetic activity as a result of an 
increased intracranial pressure (Kox et al., 2008) and/or activation of the pulmonary vagal 
reflex (Cernak and Noble-Haeusslein, 2010) may cause the reduction in heart rate 
(bradycardia) and dilation of peripheral blood vessels (hypotension) observed immediately 
after injury. Endocrine abnormalities such as growth hormone deficiency, hypothyroidism, 
and adrenal insufficiency are also common with insomnia following TBI (Englander et al., 
2010). Some of these physical manifestations due to endocrine changes may be temporary 
and completely dissipate within days or weeks, while others may continue on for a year or 
more after the brain injury (Masel and DeWitt, 2010). Whether these mechanisms persist 
regardless of injury mechanism, location, and severity as well as their relationship to the 
sleep disturbances caused by TBI remains to be determined.
4. Sleep and symptoms
Sleep disturbance may exacerbate these other symptoms of TBI, impede the rehabilitation 
process, and limit the ability to return to work leading to poor occupational outcomes 
(Cohen et al., 1992; Ouellet and Morin, 2004). In the following sections we discuss how 
sleep affects neuropsychiatric and physical symptoms. In the final section, we address 
potential treatment options for patients with sleep disturbance.
4.1. Effect of sleep on neuropsychiatric symptoms of TBI
While the role of sleep has been widely accepted for years in the maintenance of the brain, 
recent evidence suggests that reduced or inadequate sleep impairs cognition and mood. 
Sleep disorders are especially common in patients with neurodegeneration, such as 
Alzheimer’s disease (Villa et al., 2015). Emerging evidence implicates sleep in the most 
basic of neurological functions, namely the exchange of metabolic wastes associated with 
neurological homeostasis. Specifically, the Nedergaard laboratory has demonstrated that 
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sleep is integral in the function of the glymphatic system. The glymphatic system functions 
in waste clearance and acts as the lymphatic complex of the brain. Natural sleep or 
anesthesia accounts for an increase in interstitial space that facilitates the subsequent 
exchange of cerebrospinal fluid (CSF) with interstitial fluid. This system works to increase 
the clearance of metabolic waste products and accumulated proteins through the process of 
sleep (Xie et al., 2013). Nedergaard and colleagues also showed that disruption of this 
system following TBI could lead to accumulated tau in their mouse model. This finding may 
explain the heightened risk of AD and CTE in those with a history of neurotrauma (Iliff et 
al., 2014). Orexin levels are also increased following sleep disruption, which contributes to 
cognitive decline (Malkki, 2014).
4.2. Relationship of sleep and physical manifestations of TBI
Sleep disturbance from mild TBI may exacerbate a number of the physical health symptoms. 
Several studies have cited post-traumatic headache and other pain complaints as important 
factors affecting sleep in mild TBI (Beetar et al., 1996; Chaput et al., 2009; Hou et al., 
2013). In a study that surveyed patients in the first six weeks post-injury, those with 
subjective sleep complaints were 3 times more likely to develop concomitant headaches 
(Chaput et al., 2009). In a separate study involving patients surveyed at a long-term follow 
up (an average of 33 months since injury), a significant association was also observed 
between headache and/or dizziness and the presence of insomnia in TBI patients (Hou et al., 
2013). Of note, a recent study by Khoury and colleagues found that pain affected the sleep 
parameters in mild TBI patients (Khoury et al., 2013). They found that mild TBI patients 
with pain showed an increase in rapid EEG frequency bands mostly during REM and slow-
wave sleep (alpha intrusion) compared to mild TBI patients without pain and controls, 
suggesting pain may be a critical factor in inducing or causing poor sleep in this population 
(Khoury et al., 2013).
4.3. Treatment options available for treating sleep disorders
There are several psychiatric and pharmacologic treatment options available for treatment of 
sleep disturbance after TBI. Cognitive behavioral therapy (CBT) has been used in treatment 
of insomnia, but there are few reports specifically addressing individuals with TBI. CBT 
was used in a small study of 11 individuals with TBI and insomnia 8 weeks after injury. The 
techniques included stimulus control, sleep restriction, cognitive restructuring, sleep hygiene 
education, and fatigue management. With these techniques there was a 54% reduction in 
total wake time and average sleep efficiency improved from 77.2 to 90.9% at 3-month 
follow-up across participants compared to a control group. Improvement in sleep was 
accompanied by reduction in fatigue symptoms (Ouellet and Morin, 2007). Given the 
association of TBI with disruptions in circadian rhythms, another potential treatment 
modality to improve sleep consolidation (memory storage during sleep) is light therapy 
(Ouellet and Morin, 2004). Regarding pharmaceutical treatments, one approach is to use 
melatonin-like compounds. Melatonin is an endogenous neurohormone agent synthesized in 
the pineal gland and is involved in maintenance of circadian rhythms. Levels of melatonin 
are reduced in individuals who have suffered TBI (Paparrigopoulos et al., 2006). Synthetic 
melatonin can have anti-oxidant and anti-inflammation properties (Naseem and Parvez, 
2014). It has also been shown to be anti-apoptotic and reduce calcium influx in a rat model 
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of TBI (Yuruker et al., 2015). Ramelteon, a melatonin agonist, has been shown to decrease 
sleep latency and improve total sleep time in an elderly population and improve memory in 
individuals with chronic primary insomnia (Erman et al., 2006), but has yet to be 
specifically studied in the TBI population. Benzodiazepines and atypical GABA agonists are 
commonly used in sleep disorders but should be used with caution in the TBI population due 
to their effects on cognition and adverse effects on neuroplasticity (Larson and Zollman, 
2010).
5. Mechanistic consequences of sleep disruption
Sleep disruption can impair the circadian rhythm and may lead to altered homeostasis. 
Several key systems within the body become dysfunctional with continued sleep 
disturbance. In the following sections, we highlight changes in metabolomics, vasculature, 
and neurogenesis that occur following sleep disruption. In the final section we discuss how 
sleep disruption can contribute to neurodegeneration over time.
5.1. Sleep disruption and metabolomic compromise
Sleep disruption increases susceptibility to metabolic disorders such as obesity and the 
metabolic syndrome likely through epigenetic changes (Khalyfa et al., 2014). The epigenetic 
changes may lead to altered brain chemistry and metabolism (Viant et al., 2005). Recent 
evidence using proton nuclear magnetic resonance has shown that 24 h of sleep deprivation 
in humans increases a series of brain metabolites acutely (Davies et al., 2014), which may be 
further exacerbated by injury (Glenn et al., 2013). Brain metabolites are therefore being 
investigated as potential biomarkers for TBI (Wang and Yu, 2013). Aspartate, an indicator 
of excitatory neurotransmission, was significantly increased in a cohort of TBI patients 
whereas total creatinine, a bioenergetics marker, was decreased (Glenn et al., 2013). In 
rodents, lactate, valine, and ascorbate, measures indicative of hypoxia, specific 
neurochemical changes, and oxidative stress, respectively are acutely increased following 
TBI and may reflect pathological mechanism (Harris et al., 2012). These metabolites need 
further verification in human TBI patients (Lemaire et al., 2011). Recent evidence indicates 
that the lactate/pyruvate ratio is predictive of sleep fragmentation following TBI using mass 
spectroscopy. An increased lactate/pyruvate ratio is associated with abnormal metabolism as 
well as a unique protein profile and has been identified in the cerebral microdialysis samples 
collected from patients in the 96 h immediately following TBI (Marcoux et al., 2008). These 
unique profiles link metabolic problems and cellular damage in the early hours following 
brain injury. Many types of cellular stress alter protein synthesis by activating the unfolded 
protein response (UPR). This response is essential for eliminating misfolded and damaged 
proteins and would be expected to play a major role following various types of brain injury. 
Various animal studies indicate the UPR is compromised in aged as well as sleep disrupted 
subjects (Naidoo, 2009). The UPR is impaired in old mice relative to young mice (Naidoo et 
al., 2008). Targeting the UPR pharmacologically and restoring the appropriate response may 
provide an avenue to reduce the consequences of sleep fragmentation and restore metabolic 
homeostasis.
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5.2. Sleep disruption and vascular compromise
Vascular dilation occurs in response to neuronal activity and is believed necessary to 
increase blood flow and supply sufficient nutrients to sustain the neuronal response. Further, 
this hemodynamic response is compromised following sleep disruption and the blunting of 
the vascular response increased as sleep loss increased (Schei and Rector, 2011). Thus, it 
would appear intuitive that recovery from brain trauma would require adequate sleep and 
that the sleep disruption accompanying TBI may be detrimental. Thus, sleep is an important 
activity essential for maintaining vascular homeostasis and its loss may compromise other 
aspects of the vasculature that further compromise the injured brain. For example, resting 
blood pressure increases in humans deprived of sleep although heart rate and sympathetic 
nerve activity do not appear to be affected (Kato et al., 2000). Interestingly, sleep 
deprivation does not impair the brain’s reflex control of cardiovascular function in the 
orthostatic condition of waking (Muenter et al., 2000), but can cause changes to sleep 
architecture. However, sleep deprivation can increase the risk of hypertension, vasospasm, 
and blood–brain barrier (BBB) disruption (Plante, 2006). These alterations to the 
cerebrovasculature can induce more detrimental effects that lead to further neuronal injury 
following TBI.
Sleep apnea which involves both sleep disruption and hypoxia causes hypertension by 
increasing oxidative stress and inflammation, which are risk factors for ischemic stroke and 
neurodegeneration (Kohler and Stradling, 2010). Acute sleep loss of 34–37 h also influences 
the immune response by increasing the blood levels of the inflammatory cytokine tumor 
necrosis factor alpha (TNF-α) (Chennaoui et al., 2011). Moreover, acute as well aschronic 
sleep deprivation impairs human endothelial vasodilation (Dettoni et al., 2012; Sauvet et al., 
2010). Endothelial function following sleep deprivation and TBI is also disrupted in rodents. 
A pre-clinical study revealed that endothelial dysfunction is associated with the nitric oxide 
(NO) synthase pathway, independent of the changes in blood pressure and the sympathetic 
nervous system (Sauvet et al., 2014). These results suggest sleep plays an integral role in 
vascular integrity and has a powerful role in recovery post-injury.
Sleep disturbance can cause cerebral vasospasm, or an uneven expansion/contraction of 
blood vessels, which limits blood delivery to neuronal cells (Fletcher, 2000). TBI also can 
lead to severe vasospasm (Kramer et al., 2013), and in conjunction with chronic sleep 
deprivation can deplete energy supply to the point of neuronal cell death (Zhang et al., 
2010). Sleep deprivation also increases blood oxygen saturation and reduces hemodynamic 
responses leading to decreased vascular compliance (Krieger and Egan, 2013). 
Hemodynamic alterations during sleep disruption have contributed to extended coronary 
vasospasm in human subjects (Somers et al., 1993).
Lastly, recent discoveries indicate that sleep deprivation can impair BBB function (Gomez-
Gonzalez et al., 2013). Depriving a rodent of REM sleep leads to an increase in BBB tracer 
permeability and a decrease in the expression of vasoactive substances. In addition several 
tight junction proteins in brain microvessels of the BBB become disrupted (He et al., 2014). 
The breakdown of the rodent BBB can be seen from basement membrane compromise with 
electron microscopy and increased Evan’s blue extravasation (Gomez-Gonzalez et al., 
2013). Total sleep deprivation was also shown to increase human serum levels of brain 
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specific proteins including neuron-specific enolase and S100 calcium binding protein B, 
which could indicate neuronal damage, BBB dysfunction or both (Benedict et al., 2014). 
These findings suggest that sleep deprivation can cause BBB dysfunction, and that this 
dysfunction allows blood–borne substances to enter the brain and promote excitotoxic 
events that trigger neuronal cell death (Fig. 1). TBI in a mouse model caused BBB 
disruption that led to damage of aquaporin channels. This in turn limits the removal of 
hyperphosphorylated tau by the glymphatic system during sleep (Iliff et al., 2014). 
Consequently, sleep deprivation and its detrimental effects on the BBB and the brain waste 
clearance system may work in conjunction with the deleterious effects of TBI, exacerbating 
neuronal damage and death
5.3. Sleep disruption and altered neuroplasticity
Sleep is also an important activity for brain plasticity (Alkadhi et al., 2013). Studies have 
shown that sleep disruption inhibits long-term potentiation, which may result in impaired 
synaptic growth and neurogenesis (Gronli et al., 2013). A recent study by Joo and colleagues 
demonstrated that patients suffering from chronicinsomnia and sleep loss had structural 
differences in the hippocampus, including decreased hippocampal volume determined 
through magnetic resonance imaging (MRI) (Joo et al., 2014). In another study, an increase 
in hippocampal neurons in the dentate gyrus was observed in sleep-deprived rats (Grassi 
Zucconi et al., 2006), which may be a compensatory mechanism. In rats subjected to 24-
hour sleep deprivation following TBI, there was a spike in initial cell number after injury 
that was drastically attenuated overtime (Martinez-Vargas et al., 2012) (Fig. 2). These 
alterations in the hippocampus, a key brain area for learning and memory, may explain the 
prominent cognitive deficits seen in post-TBI patients. Indeed, in a rodent model of TBI, 
sleep disruption has resulted in impaired learning and memory (Skopin et al., 2014). 
Additionally, in a prospective study of humans with TBI, the duration of daytime sleep 
partially mediated the positive relationship between the score on the Glasgow Coma Scale 
and the recovery of cognitive function–controlling for total daytime sleep reduced the 
relationship (Chiu et al., 2014).
5.4. Sleep disturbance and neurodegeneration
Sleep fragmentation can have long-term negative consequences on recovery and can 
potentially contribute to the progression of injury in brain trauma. Patients with TBI 
subjected to more days of hourly neurologic evaluation had a significantly greater length of 
stay in the hospital (Stone et al., 2014). Recent evidence has found that TBI patients need 
more sleep than average and often under-estimate their need for sleep as evidenced by sleep 
propensity measures. This increased sleep need may play a role in recuperation during the 
immediate period following TBI but the persistence of the need for many years after is 
difficult to explain. The persistent increased sleep need may reflect sleep insufficiency due 
to poor quality sleep (Sommerauer et al., 2013). Patients are often in isolated rooms as well 
which limits social interaction and worsens outcome (Riechers et al., 2013). When a patient 
is sleep deprived post-injury, one of the earliest clinical signs is the inability to sustain 
focused attention (Bloomfield et al., 2010). A possible reason is that extended wakefulness 
has been shown to contribute to alteration/deficiencies in tyrosine hydroxylase positive of 
wake-active neurons in the locus ceruleus (Zhang et al., 2014). Paradoxically, sleep 
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deprivation before injury in experimental animals diminishes histopathologic changes 
(Martinez-Vargas et al., 2012). Further studies are needed to determine the potential 
neuroprotective versus neurodegenerative effects of sleep deprivation.
With sleep deprivation, the brain becomes primed to secondary injury cascades and 
therefore is preconditioned to glutamate excitotoxicity and NO mediated damage (Novati et 
al., 2012; Obukuro et al., 2013). Damaged neurons from TBI are often found in regions 
controlling behavior (Garcia-Garcia et al., 2011), which may result in increased 
neuropsychiatric symptoms characteristic of many neurodegenerative diseases. In a rodent 
model of sleep disruption and fragmentation, for example, animals displayed more 
impulsive-like behavior and had increased levels of corticosterone (Tartar et al., 2009). Not 
surprisingly sleep wake disturbances have been reported in diseases such as AD, Parkinson’s 
disease, and CTE (Belaid et al., 2014; Collen et al., 2012; Lim et al., 2014). Ongoing work is 
needed to investigate how TBI sleep disruption can accelerate the progression toward these 
neurodegenerative diseases.
Two primary theories among many of sleep are currently under investigation. First, the 
metabolism theory posits that sleep is critical to maintain appropriate ATP production as 
well as restoration of the immune system and the regulation of inflammation (Zielinski et 
al., 2013) (Fig. 3). This beneficial process suggests that sleep allows energy stores to be 
generated enhancing cell functions during times of wakefulness. Additionally it prepares the 
body to maintain defense mechanisms and alter the inflammatory response. A second theory 
is the glymphatic theory of sleep (Iliff et al., 2014). During sleep, extracellular spaces are 
increased to permit greater flow of cerebrospinal fluid through the parenchyma allowing for 
greater clearance of wastes generated during times of wakefulness. This clearance removes 
any remaining metabolites and toxins that may be harmful to neurons (Fig. 4). Sleep 
deprivation following injury supports both of these theories. Without sleep to generate 
necessary ATP and protein synthesis, cell functions may be impaired or lost. This results in 
impaired synaptic plasticity and decreased neurogenesis. Additionally, the regulation of the 
inflammatory response is critical to neurological protection. Overactive neuroinflammation 
may inhibit recovery and repair as well as trigger further neural damage and death. Under 
the second theory, waste productions from damaged and dying cells cannot be cleared and 
limits the survival of regenerated neurons. Additionally, impaired clearances of wastes will 
result in increased activation of inflammatory responses. Thus, sleep deprivation and 
disruption may inhibit waste clearance and energy production resulting in inhibited neuron 
repair. Furthermore, sleep deprivation may activate secondary mechanisms of injury 
including oxidative stress and the UPR. Rodent models have shown that sleep fragmentation 
following injury can lead to oxidative damage of DNA (Everson et al., 2014), and the UPR 
has recently been shown to account for sleep fragmentation in the elderly (Brown et al., 
2014). It is therefore likely that these secondary injury pathways con-tribute to the pathology 
of sleep fragmentation and early onset of neurodegenerative disease following TBI.
6. Conclusions and future directions
Sleep disruption is an important and often overlooked outcome of TBI. Although sleep 
disturbances have been frequently reported, research is needed to address how sleep 
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disturbances associated with TBI change over time and what sleep disruption informs us 
about the injured brain. Continued pre-clinical work needs to focus on disruptions of the 
glymphatic system and the clearance of metabolic waste. Additionally, it will be important 
to determine if and how repetitive injuries impact the sleep disturbance associated with brain 
trauma and if the injuries cause summative or exponential decline. Current evidence 
suggests it is necessary to successfully manage sleep disturbance early following brain 
injury because sleep disruption following TBI is concomitant with multiple neuropsychiatric 
and cognitive symptoms. In addition, physical manifestations of TBI such as headaches can 
worsen with sleep disruption or can even cause sleep disruption. Future clinical work will 
need to evaluate if treating sleep disturbance improves neuropsychiatric and physical 
symptoms of TBI. In this review, we discussed potential mechanistic contributions of sleep 
disruption including metabolomic alterations, vascular changes, and disruption of 
neurogenesis. Other pathways warranting further investigation include the UPR and 
oxidative stress. In this review, we also highlighted how sleep disruption following TBI may 
contribute to the development of neurodegenerative disease. Continued exploration into how 
sleep disruption contributes to tauopathies in particular is warranted. We propose that 




Research Funding and Development Grant West Virginia University. Brandon Lucke-Wold and Aric Logsdon were 
supported by American Foundation of Pharmaceutical Education Pre-doctoral Fellowships. Brandon Lucke-Wold 
also was funded by an American Medical Association Foundation Seed-Grant and a Neurosurgery Research and 
Education Foundation Medical Student Summer Research Fellowship.
References
Abdel Malik P, Husted J, Chow EW, Bassett AS. Childhood head injury and expression of 
schizophrenia in multiply affected families. Arch. Gen. Psychiatry. 2003; 60:231–236. [PubMed: 
12622655] 
Alderfer BS, Arciniegas DB, Silver JM. Treatment of depression following traumatic brain injury. J. 
Head Trauma Rehabil. 2005; 20:544–562. [PubMed: 16304490] 
Alkadhi K, Zagaar M, Alhaider I, Salim S, Aleisa A. Neurobiological consequences of sleep 
deprivation. Curr. Neuropharmacol. 2013; 11:231–249. [PubMed: 24179461] 
Arciniegas DB, Topkoff J, Silver JM. Neuropsychiatric aspects of traumatic brain injury. Curr. Treat. 
Options Neurol. 2000; 2:169–186. [PubMed: 11096746] 
Ayalon L, Borodkin K, Dishon L, Kanety H, Dagan Y. Circadian rhythm sleep disorders following 
mild traumatic brain injury. Neurology. 2007; 68:1136–1140. [PubMed: 17404196] 
Bailey NW, Hoy KE, Maller JJ, Segrave RA, Thomson R, Williams N, Daskalakis ZJ, Fitzgerald PB. 
An exploratory analysis of go/nogo event-related potentials in major depression and depression 
following traumatic brain injury. Psychiatry Res. 2014; 224:324–334. [PubMed: 25452196] 
Bakchine S, Lacomblez L, Benoit N, Parisot D, Chain F, Lhermitte F. Manic-like state after bilateral 
orbitofrontal and right temporoparietal injury: efficacy of clonidine. Neurology. 1989; 39:777–781. 
[PubMed: 2725871] 
Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL. Sleep-wake disturbances 6 months after 
traumatic brain injury: a prospective study. Brain. 2007; 130:1873–1883. [PubMed: 17584779] 
Lucke-Wold et al. Page 12













Beetar JT, Guilmette TJ, Sparadeo FR. Sleep and pain complaints in symptomatic traumatic brain 
injury and neurologic populations. Arch. Phys. Med. Rehabil. 1996; 77:1298–1302. [PubMed: 
8976315] 
Belaid H, Adrien J, Laffrat E, Tande D, Karachi C, Grabli D, Arnulf I, Clark SD, Drouot X, Hirsch 
EC, Francois C. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and 
pedunculopontine nucleus lesion. J. Neurosci. 2014; 34:9124–9133. [PubMed: 24990932] 
Benedict C, Cedernaes J, Giedraitis V, Nilsson EK, Hogenkamp PS, Vagesjo E, Massena S, Pettersson 
U, Christoffersson G, Phillipson M, Broman JE, Lannfelt L, Zetterberg H, Schioth HB. Acute 
sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium 
binding protein B (S-100B) in healthy young men. Sleep. 2014; 37:195–198. [PubMed: 24470708] 
Bloomfield IL, Espie CA, Evans JJ. Do sleep difficulties exacerbate deficits in sustained attention 
following traumatic brain injury? J. Int. Neuropsychol. Soc. 2010; 16:17–25. [PubMed: 19796442] 
Brown G, Chadwick O, Shaffer D, Rutter M, Traub M. A prospective study of children with head 
injuries: III. Psychiatric sequelae. Psychol. Med. 1981; 11:63–78. [PubMed: 7208747] 
Brown MK, Chan MT, Zimmerman JE, Pack AI, Jackson NE, Naidoo N. Aging induced endoplasmic 
reticulum stress alters sleep and sleep homeostasis. Neurobiol. Aging. 2014; 35:1431–1441. 
[PubMed: 24444805] 
Burns S, Kappenberg R, McKenna A, Wood C. Brain injury: personality, psychopathology and 
neuropsychology. Brain Inj. 1994; 8:413–427. [PubMed: 7951204] 
Castriotta RJ, Wilde MC, Lai JM, Atanasov S, Masel BE, Kuna ST. Prevalence and consequences of 
sleep disorders in traumatic brain injury. J. Clin. Sleep Med. 2007; 3:349–356. [PubMed: 
17694722] 
Cernak I, Noble-Haeusslein LJ. Traumatic brain injury: an overview of pathobiology with emphasis on 
military populations. J. Cereb. Blood Flow Metab. 2010; 30:255–266. [PubMed: 19809467] 
Chaput G, Giguere JF, Chauny JM, Denis R, Lavigne G. Relationship among subjective sleep 
complaints, headaches, and mood alterations following a mild traumatic brain injury. Sleep Med. 
2009; 10:713–716. [PubMed: 19147402] 
Chennaoui M, Sauvet F, Drogou C, Van Beers P, Langrume C, Guillard M, Gourby B, Bourrilhon C, 
Florence G, Gomez-Merino D. Effect of one night of sleep loss on changes in tumor necrosis 
factor alpha (TNF-alpha) levels in healthy men. Cytokine. 2011; 56:318–324. [PubMed: 
21737301] 
Chiu HY, Lo WC, Chiang YH, Tsai PS. The effects of sleep on the relationship between brain injury 
severity and recovery of cognitive function: a prospective study. Int. J. Nurs. Stud. 2014; 51:892–
899. [PubMed: 24246095] 
Cipriani G, Lucetti C, Danti S, Nuti A. Sleep disturbances and dementia. Psychogeriatrics. 2014; 
15:65–74. [PubMed: 25515641] 
Clinchot DM, Bogner J, Mysiw WJ, Fugate L, Corrigan J. Defining sleep disturbance after brain 
injury. Am. J. Phys. Med. Rehabil. 1998; 77:291–295. [PubMed: 9715917] 
Cohen M, Oksenberg A, Snir D, Stern MJ, Groswasser Z. Temporally related changes of sleep 
complaints in traumatic brain injured patients. J. Neurol. Neurosurg. Psychiatry. 1992; 55:313–
315. [PubMed: 1583518] 
Collen J, Orr N, Lettieri CJ, Carter K, Holley AB. Sleep disturbances among soldiers with combat-
related traumatic brain injury. Chest. 2012; 142:622–630. [PubMed: 22459784] 
Davies SK, Ang JE, Revell VL, Holmes B, Mann A, Robertson FP, Cui N, Middleton B, Ackermann 
K, Kayser M, Thumser AE, Raynaud FI, Skene DJ. Effect of sleep deprivation on the human 
metabolome. Proc. Natl. Acad. Sci. U. S. A. 2014; 111:10761–10766. [PubMed: 25002497] 
Dettoni JL, Consolim-Colombo FM, Drager LF, Rubira MC, Souza SB, Irigoyen MC, Mostarda C, 
Borile S, Krieger EM, Moreno H Jr, Lorenzi-Filho G. Cardiovascular effects of partial sleep 
deprivation in healthy volunteers. J. Appl. Physiol. 2012; 113:232–236. [PubMed: 22539169] 
Duclos C, Beauregard MP, Bottari C, Ouellet MC, Gosselin N. The impact of poor sleep on cognition 
and activities of daily living after traumatic brain injury: a review. Aust. Occup. Ther. J. 2014; 
62:2–12. [PubMed: 25331353] 
Duffy JD, Campbell JJ 3rd. The regional prefrontal syndromes: a theoretical and clinical overview. J. 
Neuropsychiatry Clin. Neurosci. 1994; 6:379–387. [PubMed: 7841809] 
Lucke-Wold et al. Page 13













Englander J, Bushnik T, Oggins J, Katznelson L. Fatigue after traumatic brain injury: association with 
neuroendocrine, sleep, depression and other factors. Brain Inj. 2010; 24:1379–1388. [PubMed: 
20961172] 
Erman M, Seiden D, Zammit G, Sainati S, Zhang J. An efficacy, safety, and dose-response study of 
Ramelteon in patients with chronic primary insomnia. Sleep Med. 2006; 7:17–24. [PubMed: 
16309958] 
Everson CA, Henchen CJ, Szabo A, Hogg N. Cell injury and repair resulting from sleep loss and sleep 
recovery in laboratory rats. Sleep. 2014; 37:1929–1940. [PubMed: 25325492] 
Farinde A. An examination of co-occurring conditions and management of psychotropic medication 
use in soldiers with traumatic brain injury. J. Trauma Nurs. 2014; 21:153–157. (quiz 158–159). 
[PubMed: 25023837] 
Fedoroff JP, Starkstein SE, Forrester AW, Geisler FH, Jorge RE, Arndt SV, Robinson RG. Depression 
in patients with acute traumatic brain injury. Am. J. Psychiatry. 1992; 149:918–923. [PubMed: 
1609872] 
Fichtenberg NL, Zafonte RD, Putnam S, Mann NR, Millard AE. Insomnia in a post-acute brain injury 
sample. Brain Inj. 2002; 16:197–206. [PubMed: 11874613] 
Fletcher EC. Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and 
sympathetic activity. Sleep. 2000; 23(Suppl. 4):S127L 131. [PubMed: 10893085] 
Garcia-Garcia F, De la Herran-Arita AK, Juarez-Aguilar E, Regalado-Santiago C, Millan-Aldaco D, 
Blanco-Centurion C, Drucker-Colin R. Growth hormone improves hippocampal adult cell survival 
and counteracts the inhibitory effect of prolonged sleep deprivation on cell proliferation. Brain 
Res. Bull. 2011; 84:252–257. [PubMed: 21256199] 
Glenn TC, Hirt D, Mendez G, McArthur DL, Sturtevant R, Wolahan S, Fazlollahi F, Ordon M, Bilgin-
Freiert A, Ellingson B, Vespa P, Hovda DA, Martin NA. Metabolomic analysis of cerebral spinal 
fluid from patients with severe brain injury. Acta Neurochir. Suppl. 2013; 118:115–119. [PubMed: 
23564115] 
Goetz CG, Pal G. Initial management of Parkinson’s disease. BMJ. 2014; 349:g6258. [PubMed: 
25527341] 
Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, Upreti C, Kracht JM, 
Ericsson M, Wojnarowicz MW, Goletiani CJ, Maglakelidze GM, Casey N, Moncaster JA, 
Minaeva O, Moir RD, Nowinski CJ, Stern RA, Cantu RC, Geiling J, Blusztajn JK, Wolozin BL, 
Ikezu T, Stein TD, Bud-son AE, Kowall NW, Chargin D, Sharon A, Saman S, Hall GF, Moss WC, 
Cleveland RO, Tanzi RE, Stanton PK, McKee AC. Chronic traumatic encephalopathy in blast-
exposed military veterans and a blast neurotrauma mouse model. Sci. Transl. Med. 2012; 
4:134ra160.
Gomez-Gonzalez B, Hurtado-Alvarado G, Esqueda-Leon E, Santana-Miranda R, Rojas-Zamorano JA, 
Velazquez-Moctezuma J. REM sleep loss and recovery regulates blood-brain barrier function. 
Curr. Neurovasc. Res. 2013; 10:197–207. [PubMed: 23713739] 
Grafman J, Schwab K, Warden D, Pridgen A, Brown HR, Salazar AM. Frontal lobe injuries, violence, 
and aggression: a report of the Vietnam Head Injury Study. Neurology. 1996; 46:1231–1238. 
[PubMed: 8628458] 
Grassi Zucconi G, Cipriani S, Balgkouranidou I, Scattoni R. ‘One night’ sleep deprivation stimulates 
hippocampal neurogenesis. Brain Res. Bull. 2006; 69:375–381. [PubMed: 16624668] 
Gronli J, Soule J, Bramham CR. Sleep and protein synthesis-dependent synaptic plasticity: impacts of 
sleep loss and stress. Front. Behav. Neurosci. 2013; 7:224. [PubMed: 24478645] 
Harris JL, Yeh HW, Choi IY, Lee P, Berman NE, Swerdlow RH, Craciunas SC, Brooks WM. Altered 
neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological 
mechanisms. J. Cereb. Blood Flow Metab. 2012; 32:2122–2134. [PubMed: 22892723] 
Hart T, Brenner L, Clark AN, Bogner JA, Novack TA, Chervoneva I, Nakase-Richardson R, Arango-
Lasprilla JC. Major and minor depression after traumatic brain injury. Arch. Phys. Med. Rehabil. 
2011; 92:1211–1219. [PubMed: 21807140] 
He J, Hsuchou H, He Y, Kastin AJ, Wang Y, Pan W. Sleep restriction impairs blood–brain barrier 
function. J. Neurosci. 2014; 34:14697–14706. [PubMed: 25355222] 
Lucke-Wold et al. Page 14













Hinkeldey NS, Corrigan JD. The structure of head-injured patients’ neurobehavioural complaints: a 
preliminary study. Brain Inj. 1990; 4:115–133. [PubMed: 2331543] 
Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. 
Soldiers returning from Iraq. N. Engl. J. Med. 2008; 358:453–463. [PubMed: 18234750] 
Holsinger T, Steffens DC, Phillips C, Helms MJ, Havlik RJ, Breitner JC, Guralnik JM, Plassman BL. 
Head injury in early adulthood and the lifetime risk of depression. Arch. Gen. Psychiatry. 2002; 
59:17–22. [PubMed: 11779276] 
Hou L, Han X, Sheng P, Tong W, Li Z, Xu D, Yu M, Huang L, Zhao Z, Lu Y, Dong Y. Risk factors 
associated with sleep disturbance following traumatic brain injury: clinical findings and 
questionnaire based study. PLoS ONE. 2013; 8:e76087. [PubMed: 24098425] 
Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, Singh I, Deane R, Nedergaard M. 
Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J. 
Neurosci. 2014; 34:16180–16193. [PubMed: 25471560] 
Jain A, Mittal RS, Sharma A, Sharma A, Gupta ID. Study of insomnia and associated factors in 
traumatic brain injury. Asian J. Psychiatry. 2014; 8:99–103.
Joo EY, Kim H, Suh S, Hong SB. Hippocampal substructural vulnerability to sleep disturbance and 
cognitive impairment in patients with chronic primary insomnia: magnetic resonance imaging 
morphometry. Sleep. 2014; 37:1189–1198. [PubMed: 25061247] 
Jorge R, Robinson RG. Mood disorders following traumatic brain injury. Int. Rev. Psychiatry. 2003; 
15:317–327. [PubMed: 15276953] 
Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Depression and anxiety following traumatic brain 
injury. J. Neuropsychiatry Clin. Neurosci. 1993; 5:369–374. [PubMed: 8286933] 
Kato M, Phillips BG, Sigurdsson G, Narkiewicz K, Pesek CA, Somers VK. Effects of sleep 
deprivation on neural circulatory control. Hypertension. 2000; 35:1173–1175. [PubMed: 
10818083] 
Kaufman Y, Tzischinsky O, Epstein R, Etzioni A, Lavie P, Pillar G. Long-term sleep disturbances in 
adolescents after minor head injury. Pediatr. Neurol. 2001; 24:129–134. [PubMed: 11275462] 
Khalyfa A, Carreras A, Almendros I, Hakim F, Gozal D. Sex dimorphism in late gestational sleep 
fragmentation and metabolic dysfunction in offspring mice. Sleep. 2014; 63:3230–3241.
Khoury S, Chouchou F, Amzica F, Giguere JF, Denis R, Rouleau GA, Lavigne GJ. Rapid EEG 
activity during sleep dominates in mild traumatic brain injury patients with acute pain. J. 
Neurotrauma. 2013; 30:633–641. [PubMed: 23510169] 
Klonoff H. Head injuries in children: predisposing factors accident conditions, accident proneness and 
sequelae. Am. J. Public Health. 1971; 61:2405–2417. [PubMed: 5128613] 
Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleepapnea. Nat. Rev. Cardiol. 
2010; 7:677–685. [PubMed: 21079639] 
Kox M, Pompe JC, Pickkers P, Hoedemaekers CW, van Vugt AB, van der Hoeven JG. Increased vagal 
tone accounts for the observed immune paralysis in patients with traumatic brain injury. 
Neurology. 2008; 70:480–485. [PubMed: 18250293] 
Kramer DR, Winer JL, Pease BA, Amar AP, Mack WJ. Cerebral vasospasmin traumatic brain injury. 
Neurol. Res. Int. 2013; 2013:415813. [PubMed: 23862062] 
Krieger SN, Egan GF. Let the vessels rest. Sleep. 2013; 36:1415–1416. [PubMed: 24082298] 
Larson EB, Zollman FS. The effect of sleep medications on cognitive recovery from traumatic brain 
injury. J. Head Trauma Rehabil. 2010; 25:61–67. [PubMed: 20051895] 
Lavigne G, Khoury S, Chauny JM, Desautels A. Pain and sleep in post-concussion/mild traumatic 
brain injury. Pain. 2015; 156(Suppl. 1):S75L 85. [PubMed: 25789439] 
Lemaire JJ, Cosnard G, Sakka L, Nuti C, Gradkowski W, Mori S, Hermoye L. White matter anatomy 
of the human deep brain revisited with high resolution DTI fibre tracking. Neurochirurgie. 2011; 
57:52–67. [PubMed: 21530985] 
Lewis L, Rosenberg SJ. Psychoanalytic psychotherapy with brain-injured adult psychiatric patients. J. 
Nerv. Ment. Dis. 1990; 178:69–77. [PubMed: 2405101] 
Lim MM, Gerstner JR, Holtzman DM. The sleep-wake cycle and Alzheimer’s disease: what do we 
know? Neurodegener. Dis. Manag. 2014; 4:351–362.
Lucke-Wold et al. Page 15













Lux WE. A neuropsychiatric perspective on traumatic brain injury. J. Rehabil. Res. Dev. 2007; 
44:951–962. [PubMed: 18075952] 
Macera CA, Aralis HJ, Rauh MJ, MacGregor AJ. Do sleep problems mediate the relationship between 
traumatic brain injury and development of mental health symptoms after deployment? Sleep. 
2013; 36:83–90. [PubMed: 23288974] 
MacGregor AJ, Dougherty AL, Tang JJ, Galarneau MR. Postconcussive symptom reporting among US 
combat veterans with mild traumatic brain injury from Operation Iraqi Freedom. J. Head Trauma 
Rehabil. 2013; 28:59–67. [PubMed: 22688214] 
Mahmood O, Rapport LJ, Hanks RA, Fichtenberg NL. Neuropsychological performance and sleep 
disturbance following traumatic brain injury. J. Head Trauma Rehabil. 2004; 19:378–390. 
[PubMed: 15597029] 
Malkesman O, Tucker LB, Ozl J, McCabe JT. Traumatic brain injury – modeling neuropsychiatric 
symptoms in rodents. Front. Neurol. 2013; 4:157. [PubMed: 24109476] 
Malkki H. Alzheimer disease: increased orexin level correlates with sleep disruption and cognitive 
decline in Alzheimer disease. Nat. Rev. Neurol. 2014; 10:672. [PubMed: 25348006] 
Mallya S, Sutherland J, Pongracic S, Mainland B, Ornstein TJ. The manifestation of anxiety disorders 
after traumatic brain injury: a review. J. Neurotrauma. 2015; 32:411–421. [PubMed: 25227240] 
Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in 
psychiatric patients. Am. J. Psychiatry. 1999; 156:181–189. [PubMed: 9989552] 
Marcoux J, McArthur DA, Miller C, Glenn TC, Villablanca P, Martin NA, Hovda DA, Alger JR, 
Vespa PM. Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-
pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit. Care 
Med. 2008; 36:2871–2877. [PubMed: 18766106] 
Martinez-Vargas M, Estrada Rojo F, Tabla-Ramon E, Navarro-Arguelles H, Ortiz-Lailzon N, 
Hernandez-Chavez A, Solis B, Martinez Tapia R, Perez Arredondo A, Morales-Gomez J, 
Gonzalez-Rivera R, Nava-Talavera K, Navarro L. Sleep deprivation has a neuroprotective role in a 
traumatic brain injury of therat. Neurosci. Lett. 2012; 529:118–122. [PubMed: 23022503] 
Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J. Neurotrauma. 2010; 
27:1529–1540. [PubMed: 20504161] 
Masel BE, Scheibel RS, Kimbark T, Kuna ST. Excessive daytime sleepiness in adults with brain 
injuries. Arch. Phys. Med. Rehabil. 2001; 82:1526–1532. [PubMed: 11689971] 
Muenter NK, Watenpaugh DE, Wasmund WL, Wasmund SL, Maxwell SA, Smith ML. Effect of sleep 
restriction on orthostatic cardiovascular control in humans. J. Appl. Physiol. 2000; 88:966–972. 
[PubMed: 10710392] 
Naidoo N. Cellular stress/the unfolded protein response: relevance to sleep and sleep disorders. Sleep 
Med. Rev. 2009; 13:195–204. [PubMed: 19329340] 
Naidoo N, Ferber M, Master M, Zhu Y, Pack AI. Aging impairs the unfolded protein response to sleep 
deprivation and leads to proapoptotic signaling. J. Neurosci. 2008; 28:6539–6548. [PubMed: 
18579727] 
Naseem M, Parvez S. Role of melatonin in traumatic brain injury and spinal cord injury. Scientific 
World Journal. 2014:586270. [PubMed: 25587567] 
Nasrallah HA, Fowler RC, Judd LL. Schizophrenia-like illness following head injury. Psychosomatics. 
1981; 22:359–361. [PubMed: 7232675] 
Novati A, Hulshof HJ, Granic I, Meerlo P. Chronic partial sleep deprivation reduces brain sensitivity 
to glutamate N-methyl-D-aspartate receptor-mediated neurotoxicity. J. Sleep Res. 2012; 21:3–9. 
[PubMed: 21672070] 
Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui 
M, Katsuki H. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons 
through dysfunction of protein disulfide isomerase. J. Neurosci. 2013; 33:12557–12568. [PubMed: 
23904594] 
Ouellet MC, Beaulieu-Bonneau S, Morin CM. Insomnia in patients with traumatic brain injury: 
frequency, characteristics, and risk factors. J. Head Trauma Rehabil. 2006; 21:199–212. [PubMed: 
16717498] 
Lucke-Wold et al. Page 16













Ouellet MC, Morin CM. Cognitive behavioral therapy for insomnia associated with traumatic brain 
injury: a single-case study. Arch. Phys. Med. Rehabil. 2004; 85:1298–1302. [PubMed: 15295756] 
Ouellet MC, Morin CM. Subjective and objective measures of insomnia in the context of traumatic 
brain injury: a preliminary study. Sleep Med. 2006; 7:486–497. [PubMed: 16934524] 
Ouellet MC, Morin CM. Efficacy of cognitive–behavioral therapy for insomnia associated with 
traumatic brain injury: a single-case experimental design. Arch. Phys. Med. Rehabil. 2007; 
88:1581–1592. [PubMed: 18047872] 
Ouellet MC, Savard J, Morin CM. Insomnia following traumatic brain injury: a review. Neurorehabil. 
Neural Rep. 2004; 18:187–198.
Paparrigopoulos T, Melissaki A, Tsekou H, Efthymiou A, Kribeni G, Baziotis N, Geronikola X. 
Melatonin secretion after head injury: a pilot study. Brain Inj. 2006; 20:873–878. [PubMed: 
17060154] 
Parcell DL, Ponsford JL, Rajaratnam SM, Redman JR. Self-reported changes to nighttime sleep after 
traumatic brain injury. Arch. Phys. Med. Rehabil. 2006; 87:278–285. [PubMed: 16442985] 
Parcell DL, Ponsford JL, Redman JR, Rajaratnam SM. Poor sleep quality and changes in objectively 
recorded sleep after traumatic brain injury: a preliminary study. Arch. Phys. Med. Rehabil. 2008; 
89:843–850. [PubMed: 18452730] 
Paul SM. Anxiety and depression: a common neurobiological substrate? J. Clin. Psychiatry. 1988; 
49(Suppl.):13–16. [PubMed: 2844736] 
Persinger MA. Sense of a presence and suicidal ideation following traumatic brain injury: indications 
of right-hemispheric intrusions from neuropsychological profiles. Psychol. Rep. 1994; 75:1059–
1070. [PubMed: 7892368] 
Petraglia AL, Plog BA, Dayawansa S, Chen M, Dashnaw ML, Czerniecka K, Walker CT, Viterise T, 
Hyrien O, Iliff JJ, Deane R, Nedergaard M, Huang JH. The spectrum of neuro-behavioral sequelae 
following repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic 
encephalopathy (CTE). J. Neurotrauma. 2014; 31:1211–1224. [PubMed: 24766454] 
Pillar G, Averbooch E, Katz N, Peled N, Kaufman Y, Shahar E. Prevalence and risk of sleep 
disturbances in adolescents after minor head injury. Pediatr. Neurol. 2003; 29:131–135. 
[PubMed: 14580656] 
Plante GE. Sleep and vascular disorders. Metabolism. 2006; 55:S45–S49. [PubMed: 16979427] 
Pope HG Jr, McElroy SL, Satlin A, Hudson JI Jr, Keck PE, Kalish R. Head injury, bipolar disorder, 
and response to valproate. Compr. Psychiatry. 1988; 29:34–38. [PubMed: 3125002] 
Quinto C, Gellido C, Chokroverty S, Masdeu J. Posttraumatic delayed sleep phase syndrome. 
Neurology. 2000; 54:250–252. [PubMed: 10636163] 
Rao V, Lyketsos C. Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics. 2000; 
41:95–103. [PubMed: 10749946] 
Riechers RG, Shuster JL, Bryan KJ, Burant CJ, Ball SL. Prior housing conditions and sleep loss may 
affect recovery from brain injury in rats: a pilot study. J. Rehabil. Res. Dev. 2013; 50:455–462. 
[PubMed: 23934866] 
Rogers JM, Read CA. Psychiatric comorbidity following traumatic brain injury. Brain Inj. 2007; 
21:1321–1333. [PubMed: 18066935] 
Sauvet F, Florence G, Van Beers P, Drogou C, Lagrume C, Chaumes C, Ciret S, Leftheriotis G, 
Chennaoui M. Total sleep deprivation alters endothelial function in rats: a nonsympathetic 
mechanism. Sleep. 2014; 37:465–473. [PubMed: 24587568] 
Sauvet F, Leftheriotis G, Gomez-Merino D, Langrume C, Drogou C, Van Beers P, Bourrilhon C, 
Florence G, Chennaoui M. Effect of acute sleep deprivation on vascular function in healthy 
subjects. J. Appl. Physiol. 2010; 108:68–75. [PubMed: 19910332] 
Schei JL, Rector DM. Evoked electrical and cerebral vascular responses during sleep and following 
sleep deprivation. Prog. Brain Res. 2011; 193:233–244. [PubMed: 21854966] 
Scholten AC, Haagsma JA, Panneman MJ, van Beeck EF, Polinder S. Traumatic brain injury in the 
Netherlands: incidence, costs and disability-adjusted life years. PLOS ONE. 2014; 9:e110905. 
[PubMed: 25343447] 
Lucke-Wold et al. Page 17













Schreiber S, Barkai G, Gur-Hartman T, Peles E, Tov N, Dolberg OT, Pick CG. Long-lasting sleep 
patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects. 
Sleep Med. 2008; 9:481–487. [PubMed: 17638592] 
Shekleton JA, Parcell DL, Redman JR, Phipps-Nelson J, Ponsford JL, Rajaratnam SM. Sleep 
disturbance and melatonin levels following traumatic brain injury. Neurology. 2010; 74:1732–
1738. [PubMed: 20498441] 
Shibui K, Uchiyama M, Okawa M. Melatonin rhythms in delayed sleep phasesyndrome. J. Biol. 
Rhythms. 1999; 14:72–76. [PubMed: 10036995] 
Simpson G, Tate R. Suicidality after traumatic brain injury: demographic, injury and clinical 
correlates. Psychol. Med. 2002; 32:687–697. [PubMed: 12102383] 
Skopin MD, Kabadi SV, Viechweg SS, Mong JA, Faden AI. Chronic decrease in wakefulness and 
disruption of sleep-wake behavior after experimental traumatic brain injury. J. Neurotrauma. 
2014; 32:289–296. [PubMed: 25242371] 
Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal 
subjects. N. Engl. J. Med. 1993; 328:303–307. [PubMed: 8419815] 
Sommerauer M, Valko PO, Werth E, Baumann CR. Excessive sleep need following traumatic brain 
injury: a case–control study of 36 patients. J. Sleep Res. 2013; 22:634–639. [PubMed: 23837871] 
Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the 
production of poststroke mood disorders. Brain. 1987; 110(Pt 4):1045–1059. [PubMed: 3651794] 
Stocker RP, Cieply MA, Paul B, Khan H, Henry L, Kontos AP, Germain A. Combat-related blast 
exposure and traumatic brain injury influence brain glucose metabolism during REM sleep in 
military veterans. Neuroimage. 2014; 99:207–214. [PubMed: 24893322] 
Stone JJ, Childs S, Smith LE, Battin M, Papadakos PJ, Huang JH. Hourly neurologic assessments for 
traumatic brain injury in the ICU. Neurol. Res. 2014; 36:164–169. [PubMed: 24410060] 
Tartar JL, Ward CP, Cordeira JW, Legare SL, Blanchette AJ, McCarley RW, Strecker RE. 
Experimental sleep fragmentation and sleep deprivation in rats increases exploration in an open 
field test of anxiety while increasing plasma corticosterone levels. Behav. Brain Res. 2009; 
197:450–453. [PubMed: 18805441] 
Tateno A, Sakayori T, Takizawa Y, Yamamoto K, Minagawa K, Okubo Y. A case of Alzheimer’s 
disease following mild traumatic brain injury. Gen. Hosp. Psychiatry. 2014; 37:97–109. 
[PubMed: 25445070] 
Teasdale TW, Engberg AW. Suicide after traumatic brain injury: a population study. J. Neurol. 
Neurosurg. Psychiatry. 2001; 71:436–440. [PubMed: 11561024] 
Theeler B, Lucas S, Riechers RG 2nd, Ruff RL. Post-traumatic headaches in civilians and military 
personnel: a comparative, clinical review. Headache. 2013; 53:881–900. [PubMed: 23721236] 
Thomsen IV. Late outcome of very severe blunt head trauma: a 10–15 year second follow-up. J. 
Neurol. Neurosurg. Psychiatry. 1984; 47:260–268. [PubMed: 6707671] 
Uchiyama M, Okawa M, Shibui K, Kim K, Tagaya H, Kudo Y, Kamei Y, Hayakawa T, Urata J, 
Takahashi K. Altered phase relation between sleep timing and core body temperature rhythm in 
delayed sleep phase syndrome and non-24-hour sleep-wake syndrome in humans. Neurosci. Lett. 
2000; 294:101–104. [PubMed: 11058797] 
Valk-Kleibeuker L, Heijenbrok-Kal MH, Ribbers GM. Mood after moderate and severe traumatic 
brain injury: a prospective cohort study. PLOS ONE. 2014; 9:e87414. [PubMed: 24503864] 
van Reekum R, Cohen T, Wong J. Can traumatic brain injury cause psychiatric disorders? J. 
Neuropsychiatry Clin. Neurosci. 2000; 12:316–327. [PubMed: 10956565] 
van Zomeren AH, van den Burg W. Residual complaints of patients two years after severe head injury. 
J. Neurol. Neurosurg. Psychiatry. 1985; 48:21–28. [PubMed: 3973618] 
Verma A, Anand V, Verma NP. Sleep disorders in chronic traumatic brain injury. J. Clin. Sleep Med. 
2007; 3:357–362. [PubMed: 17694723] 
Viant MR, Lyeth BG, Miller MG, Berman RF. An NMR metabolomic investigation of early metabolic 
disturbances following traumatic brain injury in a mammalian model. NMR Biomed. 2005; 
18:507–516. [PubMed: 16177961] 
Villa C, Ferini-Strambi L, Combi R. The synergistic relationship between Alzheimer’s disease and 
sleep disorders: an update. J. Alzheimer’s Dis. 2015 (Epub). 
Lucke-Wold et al. Page 18













Wang J, Yu G. A systems biology approach to characterize biomarkers for blood stasis syndrome of 
unstable angina patients by integrating MicroRNA and messenger RNA expression profiling. 
Evid. Base. Compl. Altern. Med. 2013; 2013:510208.
Weitzman ED, Czeisler CA, Coleman RM, Spielman AJ, Zimmerman JC, Dement W, Richardson G, 
Pollak CP. Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset 
insomnia. Arch. Gen. Psychiatry. 1981; 38:737–746. [PubMed: 7247637] 
Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O’Donnell J, Christensen DJ, Nicholson C, 
Iliff JJ, Takano T, Deane R, Nedergaard M. Sleep drives metabolite clearance from the adult 
brain. Science. 2013; 342:373–377. [PubMed: 24136970] 
Yuruker V, Naziroglu M, Senol N. Reduction in traumatic brain injury-induced oxidative stress, 
apoptosis, and calcium entry in rat hippocampus by melatonin: possible involvement of TRPM2 
channels. Metab. Brain Dis. 2015; 30:223–231. [PubMed: 25339252] 
Zhang J, Zhu Y, Zhan G, Fenik P, Panossian L, Wang MM, Reid S, Lai D, Davis JG, Baur JA, Veasey 
S. Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus 
neurons. J. Neurosci. 2014; 34:4418–4431. [PubMed: 24647961] 
Zhang JH, Fung SJ, Xi M, Sampogna S, Chase MH. Apnea produces neuronal degeneration in the 
pons and medulla of guinea pigs. Neurobiol. Dis. 2010; 40:251–264. [PubMed: 20554036] 
Zielinski MR, Dunbrasky DL, Taishi P, Souza G, Krueger JM. Vagotomy attenuates brain cytokines 
and sleep induced by peripherally administered tumor necrosis factor-alpha and 
lipopolysaccharide in mice. Sleep. 2013; 36:1227–1238. 1238A. [PubMed: 23904683] 
Lucke-Wold et al. Page 19














Sleep disruption following traumatic brain injury triggers neurodegeneration. Sleep 
disruption can lead to an increase in oxidative stress and neuroinflammation. Oxidative 
stress damages intracellular organelles while neuroinflammation causes an increase in 
cytokines. Cytokines can disrupt vascular function leading to complications such as blood 
brain barrier breakdown and vasospasm. Over time these mechanistic changes contribute to 
neurodegenerative pathology such as neurofibrillary tangles.
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Effects of sleep on neurogenesis. In the hippocampus, cells undergo neurogenesis to 
increase cell numbers. During sleep, these cells are integrated into neuronal networks 
through synaptogenesis. Once integrated into the existing cellular network, these cells have 
a greater likelihood of surviving. The surviving cells allow for maintenance of functions 
such as memory, learning, and cognition. However, when sleep is disrupted, synaptogenesis 
is decreased as well as memory consolidation. Ultimately, this change in synaptogenesis 
leads to a reduction in action potential firing. If synapses are not formed, newly generated 
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cells fail to integrate into the existing neuronal network and the cells undergo apoptosis. The 
death of these cells prevents recovery and leads to memory loss and cognitive deficiencies 
follow inginjury.
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The sleep theory of metabolism. ATP is crucial to cellular repair processes. During sleep, 
ATP production is increased allowing an elevated energy reserve that can decrease 
inflammation and contribute to enhanced cell survival. Following injury, sleep becomes 
more of a necessity for the repair and recovery of damaged and stressed cells. During sleep 
deprivation, ATP production is drastically reduced. The brain no longer can initiate repair 
and the prolonged inflammation can be detrimental, resulting in neuronal cell death. The cell 
death can eventually lead to affective disorders, memory and learning deficits, and cognitive 
dysfunction.
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Sleep disruption and the effect on the glymphatic system. During sleep, extracellular spaces 
are enlarged allowing for increased flow of interstitial fluid and increased clearance of 
wastes and metabolites. This removal of wastes lowers oxidative and endoplasmic reticulum 
stress, therefore reducing protein misfolding and tau accumulation. When the glymphatic 
system is altered during sleep disruption, the clearance of metabolites and toxins is reduced 
because the extracellular spaces fail to enlarge. Hyperphosphorylated tau can accumulate in 
this altered state, which increases the progression of tauopathies including Alzheimer’s 
disease and chronic traumatic encephalopathy.
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